The realm of single-cell genomics is continually evolving, driven by innovative technologies and partnerships. Among the latest developments, ArgenTag, a company founded in Argentina during the COVID-19 pandemic, has emerged to address a critical gap in single-cell instrumentation access in South America. With a strong belief in the potential of long-read technologies in transcriptomics, ArgenTag is making significant strides in this field.
Partnership Announcement
Today marks a pivotal moment for ArgenTag as it officially joins the PacBio Compatible Partner Program. This collaboration highlights the compatibility of ArgenTag’s Single-Cell RNA Library Kit with PacBio’s Kinnex RNA kits. Together, they empower researchers to perform long-read isoform sequencing at single-cell resolution, expanding the capabilities of transcriptomic analysis.
Advantages of Long-Read Technologies
The decision to focus on long-read sequencing is grounded in the limitations of short-read methods. Dr. Sofía Lavista Llanos, ArgenTag’s director of process development, emphasizes that short reads provide only a limited snapshot of the transcriptome. In contrast, long reads capture comprehensive information, enabling researchers to uncover complex biological insights.
Innovative Microfluidic Technology
ArgenTag’s innovative approach involves a portable, gravity-based microfluidic chip technology designed for cell partitioning and barcoding. This system utilizes microwells that not only partition cells but also incorporate beads carrying unique barcodes. This technology, which was first introduced in a scientific publication in May 2022, enhances the efficiency and scalability of long-read sequencing.
Enhanced Transcriptomic Data
When paired with PacBio’s Kinnex kits and HiFi long-read sequencing, ArgenTag’s workflow provides a streamlined benchtop method for generating full-length single-cell transcriptomic data. This capability is particularly vital for capturing the full spectrum of isoform diversity, alternative splicing events, and gene fusions—elements often overlooked in short-read approaches that focus primarily on the 3′ end.
Expanding Research Opportunities
Access to full-length isoform data at the single-cell level is a game-changer for researchers. It opens new avenues for biomarker discovery, deepens our understanding of complex gene regulation, and aids in the development of novel therapeutics. The implications of this technology are vast, potentially transforming how we approach health and disease.
Commitment to Long-Read Sequencing
ArgenTag distinguishes itself as one of the few companies dedicated to developing solutions specifically for long-read sequencing. This commitment to high-resolution, full-length isoform data equips researchers with an unprecedented level of biological clarity, an advantage that short-read platforms cannot offer.
Integrated Bioinformatics Solutions
Alongside its advanced sequencing technologies, ArgenTag provides integrated bioinformatics tools optimized for long-read data analysis. This software facilitates the demultiplexing of reads and assigns them to their respective cells, greatly simplifying the complex analysis required for long-read single-cell datasets.
Research Grant Program Announcement
In an exciting initiative, ArgenTag has announced the launch of a Single-Cell Long-Read Research Grant Program. This program will provide selected researchers with access to ArgenTag’s single-cell kit, fostering innovative and exploratory long-read single-cell projects. The application period opens on February 17, 2026, and closes on March 31, 2026.
Vision for the Future
Leandro Ciappina, CEO of ArgenTag, articulates the company’s mission to empower scientists in their quest to understand health and disease through long-read single-cell sequencing solutions. By collaborating with PacBio, ArgenTag is broadening access to high-resolution data, enabling laboratories to explore the intricate complexities of the transcriptome at an unprecedented level.
Conclusion
The partnership between ArgenTag and PacBio heralds a promising advancement in single-cell transcriptomics. As researchers gain access to long-read sequencing capabilities, the potential for groundbreaking discoveries in genomics and personalized medicine expands. Together, they are paving the way for a deeper understanding of the intricate tapestry of life at the cellular level.
- ArgenTag focuses on long-read sequencing technologies to address gaps in single-cell genomics.
- The partnership with PacBio enhances the capabilities of transcriptomic analysis.
- ArgenTag’s microfluidic technology simplifies cell partitioning and barcoding.
- Access to full-length isoform data facilitates biomarker discovery and therapeutic development.
- The Single-Cell Long-Read Research Grant Program aims to support innovative research projects.
Read more → www.genengnews.com